HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist

40.550
+0.650+1.63%

Market Closed Oct 16 16:08 CST

11.34BMarket Cap-13934P/E (TTM)

KEYMED BIO-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Assets

Current assets

Inventory

4.35%83.93M

26.65%56.35M

111.82%80.43M

171.43%44.5M

84.84%37.97M

139.45%16.39M

--20.54M

107.08%6.85M

--3.31M

Accounts receivable

127.68%12.8M

--16.09M

--5.62M

----

Advance deposits and other receivables

45.09%114.86M

49.88%135.13M

-20.42%79.17M

143.68%90.15M

90.38%99.48M

85.09%37M

--52.25M

23.77%19.99M

--16.15M

Cash and equivalents

-36.34%709.91M

40.88%851.03M

-5.18%1.12B

-60.27%604.07M

41.09%1.18B

662.56%1.52B

--833.61M

-53.91%199.41M

--432.61M

Fixed time deposit-current assets

8.32%1.73B

-27.59%1.69B

-25.50%1.6B

19.92%2.34B

1,829.77%2.14B

1,251.94%1.95B

--111.06M

--144.28M

----

Secured deposit

----

--1.78M

----

Financial assets at fair value-current assets

-48.56%137.28M

-24.90%174.37M

158.97%266.85M

334.80%232.19M

40.20%103.05M

413.77%53.4M

--73.5M

-84.33%10.39M

--66.34M

Total current assets

-11.39%2.79B

-11.19%2.94B

-11.61%3.15B

-7.59%3.31B

226.31%3.56B

840.35%3.58B

--1.09B

-26.52%380.92M

--518.41M

Non-current assets

Property, plant and equipment

11.15%864.43M

45.12%803.35M

98.39%777.73M

297.04%553.56M

275.16%392.02M

38.05%139.42M

--104.49M

4.69%100.99M

--96.47M

Advance payment

159.13%46.36M

69.90%26.91M

-79.88%17.89M

-89.69%15.84M

146.19%88.91M

537.20%153.59M

--36.11M

62.80%24.1M

--14.81M

Interests in Joint Venture

-51.33%4.12M

-44.92%5.82M

-26.13%8.47M

-47.88%10.57M

--11.47M

--20.28M

----

Intangible assets

92.71%2.51M

-25.80%1.11M

-16.04%1.3M

35.51%1.5M

448.41%1.55M

912.84%1.1M

--283K

--109K

----

Total non-current assets

10.43%1.02B

51.59%943.39M

69.49%921.08M

76.55%622.34M

222.52%543.43M

136.54%352.51M

--168.5M

6.32%149.03M

--140.17M

Total assets

-6.45%3.81B

-1.26%3.88B

-0.87%4.07B

-0.05%3.93B

225.80%4.1B

642.43%3.93B

--1.26B

-19.53%529.95M

--658.58M

Liabilities

Current liabilities

Accounts payable

-11.75%30.07M

97.73%29.49M

246.14%34.07M

435.67%14.91M

202.46%9.84M

-18.55%2.78M

--3.25M

-1.73%3.42M

--3.48M

Tax payable

--4.99M

----

Amounts payable to associated parties-current liabilities

----

-59.31%225K

--553K

-98.69%553K

----

-11.26%42.37M

--47.75M

Other payables and accrued expenses

0.18%165.4M

50.09%219.44M

103.38%165.1M

53.25%146.21M

91.29%81.18M

391.81%95.4M

--42.44M

33.83%19.4M

--14.5M

Bank loans and overdrafts

2,823.64%343.76M

-25.08%45.83M

-88.24%11.76M

--61.16M

--100M

----

Financial lease liabilities-current liabilities

-14.30%15.45M

75.37%19.43M

44.22%18.03M

-5.51%11.08M

107.78%12.5M

180.61%11.72M

--6.02M

-5.69%4.18M

--4.43M

Deferred income-current liabilities

----

-22.48%2.23M

-43.89%1.61M

--2.88M

99.51%2.87M

--1.44M

Total current liabilities

144.44%559.66M

-17.26%314.18M

-34.21%228.95M

238.79%379.7M

162.00%348.01M

39.67%112.08M

--132.83M

12.08%80.24M

--71.59M

Net current assets

-23.62%2.23B

-10.41%2.63B

-9.16%2.92B

-15.55%2.93B

235.22%3.21B

1,054.02%3.47B

--958.14M

-32.71%300.68M

--446.82M

Total assets less current liabilities

-15.45%3.25B

0.45%3.57B

2.22%3.84B

-7.06%3.55B

233.32%3.76B

749.97%3.82B

--1.13B

-23.39%449.71M

--586.99M

Non-current liabilities

Long-term bank loan

28.60%348.65M

1,052.20%331.83M

2,611.02%271.1M

--28.8M

--10M

----

Financial lease liabilities-non-current liabilities

-46.44%16.34M

3.32%21.62M

11.08%30.52M

-22.45%20.93M

18.96%27.47M

32.84%26.99M

--23.09M

-16.30%20.31M

--24.27M

Deferred tax liability

--463K

--278K

----

Deferred income-non-current liabilities

49.31%243.18M

39.42%228.19M

90.82%162.87M

1,777.18%163.67M

870.68%85.35M

28.49%8.72M

--8.79M

327.60%6.79M

--1.59M

Convertible notes and bonds

----

--5.58B

88.99%1.39B

--733.26M

Total non-current liabilities

31.03%608.63M

172.70%581.93M

278.17%464.48M

20.57%213.4M

-97.86%122.82M

-88.54%177M

--5.75B

78.98%1.54B

--862.94M

Total liabilities

68.48%1.17B

51.09%896.11M

47.28%693.44M

105.17%593.1M

-92.00%470.83M

-82.21%289.07M

--5.89B

73.86%1.62B

--934.53M

Total assets less total liabilities

-21.85%2.64B

-10.55%2.99B

-7.11%3.37B

-8.40%3.34B

178.53%3.63B

432.97%3.65B

---4.63B

-296.73%-1.09B

---275.96M

Total equity and non-current liabilities

-15.45%3.25B

0.45%3.57B

2.22%3.84B

-7.06%3.55B

233.32%3.76B

749.97%3.82B

--1.13B

-23.39%449.71M

--586.99M

Equity

Share capital

2.96%174K

-0.59%169K

-1.17%169K

-0.58%170K

280.00%171K

--45K

0.00%45K

--45K

Reserve

-21.86%2.64B

-10.60%2.99B

-8.30%3.37B

-8.51%3.34B

--3.68B

433.53%3.65B

----

---1.09B

----

Special items of shareholders' rights and interests

----

---4.62B

----

---276M

Shareholders' Equity

-21.86%2.64B

-10.60%2.99B

-7.33%3.37B

-8.51%3.34B

178.75%3.64B

433.56%3.65B

---4.62B

-296.64%-1.09B

---275.96M

Non-controlling interest

311.11%444K

146.92%502K

101.27%108K

80.85%-1.07M

-287.89%-8.52M

-2,008.68%-5.59M

---2.2M

---265K

----

Total equity

-21.85%2.64B

-10.55%2.99B

-7.11%3.37B

-8.40%3.34B

178.53%3.63B

432.97%3.65B

---4.63B

-296.73%-1.09B

---275.96M

Total equity and total liabilities

-6.45%3.81B

-1.26%3.88B

-0.87%4.07B

-0.05%3.93B

225.80%4.1B

642.43%3.93B

--1.26B

-19.53%529.95M

--658.58M

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Assets
Current assets
Inventory	4.35%83.93M	26.65%56.35M	111.82%80.43M	171.43%44.5M	84.84%37.97M	139.45%16.39M	--20.54M	107.08%6.85M	--3.31M
Accounts receivable	127.68%12.8M	--16.09M	--5.62M	----	----	----	----	----	----
Advance deposits and other receivables	45.09%114.86M	49.88%135.13M	-20.42%79.17M	143.68%90.15M	90.38%99.48M	85.09%37M	--52.25M	23.77%19.99M	--16.15M
Cash and equivalents	-36.34%709.91M	40.88%851.03M	-5.18%1.12B	-60.27%604.07M	41.09%1.18B	662.56%1.52B	--833.61M	-53.91%199.41M	--432.61M
Fixed time deposit-current assets	8.32%1.73B	-27.59%1.69B	-25.50%1.6B	19.92%2.34B	1,829.77%2.14B	1,251.94%1.95B	--111.06M	--144.28M	----
Secured deposit	----	--1.78M	----	----	----	----	----	----	----
Financial assets at fair value-current assets	-48.56%137.28M	-24.90%174.37M	158.97%266.85M	334.80%232.19M	40.20%103.05M	413.77%53.4M	--73.5M	-84.33%10.39M	--66.34M
Total current assets	-11.39%2.79B	-11.19%2.94B	-11.61%3.15B	-7.59%3.31B	226.31%3.56B	840.35%3.58B	--1.09B	-26.52%380.92M	--518.41M
Non-current assets
Property, plant and equipment	11.15%864.43M	45.12%803.35M	98.39%777.73M	297.04%553.56M	275.16%392.02M	38.05%139.42M	--104.49M	4.69%100.99M	--96.47M
Advance payment	159.13%46.36M	69.90%26.91M	-79.88%17.89M	-89.69%15.84M	146.19%88.91M	537.20%153.59M	--36.11M	62.80%24.1M	--14.81M
Interests in Joint Venture	-51.33%4.12M	-44.92%5.82M	-26.13%8.47M	-47.88%10.57M	--11.47M	--20.28M	----	----	----
Intangible assets	92.71%2.51M	-25.80%1.11M	-16.04%1.3M	35.51%1.5M	448.41%1.55M	912.84%1.1M	--283K	--109K	----
Total non-current assets	10.43%1.02B	51.59%943.39M	69.49%921.08M	76.55%622.34M	222.52%543.43M	136.54%352.51M	--168.5M	6.32%149.03M	--140.17M
Total assets	-6.45%3.81B	-1.26%3.88B	-0.87%4.07B	-0.05%3.93B	225.80%4.1B	642.43%3.93B	--1.26B	-19.53%529.95M	--658.58M
Liabilities
Current liabilities
Accounts payable	-11.75%30.07M	97.73%29.49M	246.14%34.07M	435.67%14.91M	202.46%9.84M	-18.55%2.78M	--3.25M	-1.73%3.42M	--3.48M
Tax payable	--4.99M	----	----	----	----	----	----	----	----
Amounts payable to associated parties-current liabilities	----	----	----	-59.31%225K	--553K	-98.69%553K	----	-11.26%42.37M	--47.75M
Other payables and accrued expenses	0.18%165.4M	50.09%219.44M	103.38%165.1M	53.25%146.21M	91.29%81.18M	391.81%95.4M	--42.44M	33.83%19.4M	--14.5M
Bank loans and overdrafts	2,823.64%343.76M	-25.08%45.83M	-88.24%11.76M	--61.16M	--100M	----	----	----	----
Financial lease liabilities-current liabilities	-14.30%15.45M	75.37%19.43M	44.22%18.03M	-5.51%11.08M	107.78%12.5M	180.61%11.72M	--6.02M	-5.69%4.18M	--4.43M
Deferred income-current liabilities	----	----	----	----	-22.48%2.23M	-43.89%1.61M	--2.88M	99.51%2.87M	--1.44M
Total current liabilities	144.44%559.66M	-17.26%314.18M	-34.21%228.95M	238.79%379.7M	162.00%348.01M	39.67%112.08M	--132.83M	12.08%80.24M	--71.59M
Net current assets	-23.62%2.23B	-10.41%2.63B	-9.16%2.92B	-15.55%2.93B	235.22%3.21B	1,054.02%3.47B	--958.14M	-32.71%300.68M	--446.82M
Total assets less current liabilities	-15.45%3.25B	0.45%3.57B	2.22%3.84B	-7.06%3.55B	233.32%3.76B	749.97%3.82B	--1.13B	-23.39%449.71M	--586.99M
Non-current liabilities
Long-term bank loan	28.60%348.65M	1,052.20%331.83M	2,611.02%271.1M	--28.8M	--10M	----	----	----	----
Financial lease liabilities-non-current liabilities	-46.44%16.34M	3.32%21.62M	11.08%30.52M	-22.45%20.93M	18.96%27.47M	32.84%26.99M	--23.09M	-16.30%20.31M	--24.27M
Deferred tax liability	--463K	--278K	----	----	----	----	----	----	----
Deferred income-non-current liabilities	49.31%243.18M	39.42%228.19M	90.82%162.87M	1,777.18%163.67M	870.68%85.35M	28.49%8.72M	--8.79M	327.60%6.79M	--1.59M
Convertible notes and bonds	----	----	----	----	----	----	--5.58B	88.99%1.39B	--733.26M
Total non-current liabilities	31.03%608.63M	172.70%581.93M	278.17%464.48M	20.57%213.4M	-97.86%122.82M	-88.54%177M	--5.75B	78.98%1.54B	--862.94M
Total liabilities	68.48%1.17B	51.09%896.11M	47.28%693.44M	105.17%593.1M	-92.00%470.83M	-82.21%289.07M	--5.89B	73.86%1.62B	--934.53M
Total assets less total liabilities	-21.85%2.64B	-10.55%2.99B	-7.11%3.37B	-8.40%3.34B	178.53%3.63B	432.97%3.65B	---4.63B	-296.73%-1.09B	---275.96M
Total equity and non-current liabilities	-15.45%3.25B	0.45%3.57B	2.22%3.84B	-7.06%3.55B	233.32%3.76B	749.97%3.82B	--1.13B	-23.39%449.71M	--586.99M
Equity
Share capital	2.96%174K	-0.59%169K	-1.17%169K	-0.58%170K	280.00%171K	280.00%171K	--45K	0.00%45K	--45K
Reserve	-21.86%2.64B	-10.60%2.99B	-8.30%3.37B	-8.51%3.34B	--3.68B	433.53%3.65B	----	---1.09B	----
Special items of shareholders' rights and interests	----	----	----	----	----	----	---4.62B	----	---276M
Shareholders' Equity	-21.86%2.64B	-10.60%2.99B	-7.33%3.37B	-8.51%3.34B	178.75%3.64B	433.56%3.65B	---4.62B	-296.64%-1.09B	---275.96M
Non-controlling interest	311.11%444K	146.92%502K	101.27%108K	80.85%-1.07M	-287.89%-8.52M	-2,008.68%-5.59M	---2.2M	---265K	----
Total equity	-21.85%2.64B	-10.55%2.99B	-7.11%3.37B	-8.40%3.34B	178.53%3.63B	432.97%3.65B	---4.63B	-296.73%-1.09B	---275.96M
Total equity and total liabilities	-6.45%3.81B	-1.26%3.88B	-0.87%4.07B	-0.05%3.93B	225.80%4.1B	642.43%3.93B	--1.26B	-19.53%529.95M	--658.58M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

02162 KEYMED BIO-B

KEYMED BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target